[HTML][HTML] Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer
S D'Aguanno, D Del Bufalo - Cells, 2020 - mdpi.com
The dynamic interplay between pro-death and pro-survival Bcl-2 family proteins is
responsible for a cell's fate. Due to the recognized relevance of this family in cancer …
responsible for a cell's fate. Due to the recognized relevance of this family in cancer …
BCL2 inhibitors as anticancer drugs: a plethora of misleading BH3 mimetics
R S. Soderquist, A Eastman - Molecular cancer therapeutics, 2016 - AACR
Antiapoptotic BCL2 proteins play a major role in tumor cell survival. Hence, BCL2 inhibitors
have been developed as direct inducers of apoptosis. ABT-199 (venetoclax) received …
have been developed as direct inducers of apoptosis. ABT-199 (venetoclax) received …
[HTML][HTML] The BCL-2 arbiters of apoptosis and their growing role as cancer targets
JM Adams, S Cory - Cell Death & Differentiation, 2018 - nature.com
Impaired apoptosis plays a central role in cancer development and limits the efficacy of
conventional cytotoxic therapies. Deepening understanding of how opposing factions of the …
conventional cytotoxic therapies. Deepening understanding of how opposing factions of the …
[HTML][HTML] Targeting BCL-2 in cancer: advances, challenges, and perspectives
Simple Summary Apoptosis, a programmed form of cell death, represents the main
mechanism by which cells die. Such phenomenon is highly regulated by the BCL-2 family of …
mechanism by which cells die. Such phenomenon is highly regulated by the BCL-2 family of …
Targeting BCL-2-like proteins to kill cancer cells
S Cory, AW Roberts, PM Colman, JM Adams - Trends in cancer, 2016 - cell.com
Mutations that impair apoptosis contribute to cancer development and reduce the
effectiveness of conventional anti-cancer therapies. These insights and understanding of …
effectiveness of conventional anti-cancer therapies. These insights and understanding of …
[HTML][HTML] It's time to die: BH3 mimetics in solid tumors
S Kehr, M Vogler - Biochimica et Biophysica Acta (BBA)-Molecular Cell …, 2021 - Elsevier
The removal of cells by apoptosis is an essential process regulating tissue homeostasis.
Cancer cells acquire the ability to circumvent apoptosis and survive in an unphysiological …
Cancer cells acquire the ability to circumvent apoptosis and survive in an unphysiological …
Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside
L Vela, I Marzo - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Antiapoptotic proteins of the Bcl-2 family are targets for anticancer drugs.•BH3
mimetics inhibit antiapoptotic proteins and exert in vitro antitumor activity.•Some BH3 …
mimetics inhibit antiapoptotic proteins and exert in vitro antitumor activity.•Some BH3 …
[HTML][HTML] The BCL-2 protein family, BH3-mimetics and cancer therapy
ARD Delbridge, A Strasser - Cell Death & Differentiation, 2015 - nature.com
Escape from apoptosis is a key attribute of tumour cells and facilitates chemo-resistance.
The 'BCL-2-regulated'or 'intrinsic'apoptotic pathway integrates stress and survival signalling …
The 'BCL-2-regulated'or 'intrinsic'apoptotic pathway integrates stress and survival signalling …
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
ST Diepstraten, MA Anderson, PE Czabotar… - Nature Reviews …, 2022 - nature.com
Apoptosis is a form of programmed cell death that is regulated by the balance between
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Members of the B cell lymphoma 2 (BCL-2) gene family have a central role in regulating
programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals …
programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals …